Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

The LIM-only protein FHL2 regulates cyclin D1 expression and cell proliferation.

Labalette C, Nouët Y, Sobczak-Thepot J, Armengol C, Levillayer F, Gendron MC, Renard CA, Regnault B, Chen J, Buendia MA, Wei Y.

J Biol Chem. 2008 May 30;283(22):15201-8. doi: 10.1074/jbc.M800708200. Epub 2008 Mar 31.

2.

Deficiency in the LIM-only protein FHL2 impairs assembly of extracellular matrix proteins.

Park J, Will C, Martin B, Gullotti L, Friedrichs N, Buettner R, Schneider H, Ludwig S, Wixler V.

FASEB J. 2008 Jul;22(7):2508-20. doi: 10.1096/fj.07-095521. Epub 2008 Mar 20.

PMID:
18356303
4.

FHL2 regulates cell cycle-dependent and doxorubicin-induced p21Cip1/Waf1 expression in breast cancer cells.

Martin BT, Kleiber K, Wixler V, Raab M, Zimmer B, Kaufmann M, Strebhardt K.

Cell Cycle. 2007 Jul 15;6(14):1779-88.

PMID:
17682292
5.

Deficiency in the LIM-only protein Fhl2 impairs skin wound healing.

Wixler V, Hirner S, Müller JM, Gullotti L, Will C, Kirfel J, Günther T, Schneider H, Bosserhoff A, Schorle H, Park J, Schüle R, Buettner R.

J Cell Biol. 2007 Apr 9;177(1):163-72.

6.

Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.

Wang J, Yang Y, Xia HH, Gu Q, Lin MC, Jiang B, Peng Y, Li G, An X, Zhang Y, Zhuang Z, Zhang Z, Kung HF, Wong BC.

Gastroenterology. 2007 Mar;132(3):1066-76. Epub 2006 Dec 3.

PMID:
17383428
7.

Cell senescence: hypertrophic arrest beyond the restriction point.

Blagosklonny MV.

J Cell Physiol. 2006 Dec;209(3):592-7. Review.

PMID:
17001692
8.

From the membrane to the nucleus and back again: bifunctional focal adhesion proteins.

Hervy M, Hoffman L, Beckerle MC.

Curr Opin Cell Biol. 2006 Oct;18(5):524-32. Epub 2006 Sep 5. Review.

PMID:
16908128
9.

The LIM-only protein FHL2 is a negative regulator of E4F1.

Paul C, Lacroix M, Iankova I, Julien E, Schäfer BW, Labalette C, Wei Y, Le Cam A, Le Cam L, Sardet C.

Oncogene. 2006 Sep 7;25(40):5475-84. Epub 2006 May 1.

PMID:
16652157
10.

The multifunctional roles of the four-and-a-half-LIM only protein FHL2.

Johannessen M, Møller S, Hansen T, Moens U, Van Ghelue M.

Cell Mol Life Sci. 2006 Feb;63(3):268-84. Review.

PMID:
16389449
11.

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP.

Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50. Epub 2005 Sep 30.

12.

Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.

Yu Q, Ciemerych MA, Sicinski P.

Oncogene. 2005 Oct 27;24(47):7114-9.

PMID:
16103884
13.

Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts.

Günther T, Poli C, Müller JM, Catala-Lehnen P, Schinke T, Yin N, Vomstein S, Amling M, Schüle R.

EMBO J. 2005 Sep 7;24(17):3049-56. Epub 2005 Aug 4.

14.

Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation.

Yang Y, Hou H, Haller EM, Nicosia SV, Bai W.

EMBO J. 2005 Mar 9;24(5):1021-32. Epub 2005 Feb 3.

15.

The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF.

Philippar U, Schratt G, Dieterich C, Müller JM, Galgóczy P, Engel FB, Keating MT, Gertler F, Schüle R, Vingron M, Nordheim A.

Mol Cell. 2004 Dec 22;16(6):867-80.

16.

Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin.

Labalette C, Renard CA, Neuveut C, Buendia MA, Wei Y.

Mol Cell Biol. 2004 Dec;24(24):10689-702.

17.

The LIM domain: from the cytoskeleton to the nucleus.

Kadrmas JL, Beckerle MC.

Nat Rev Mol Cell Biol. 2004 Nov;5(11):920-31. Review.

PMID:
15520811
18.

Mouse development and cell proliferation in the absence of D-cyclins.

Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E, Geng Y, Yu Q, Bhattacharya S, Bronson RT, Akashi K, Sicinski P.

Cell. 2004 Aug 20;118(4):477-91.

19.

Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancer.

Gabriel B, Mildenberger S, Weisser CW, Metzger E, Gitsch G, Schüle R, Müller JM.

Anticancer Res. 2004 Mar-Apr;24(2B):921-7.

20.

Supplemental Content

Support Center